Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.

about

Multicenter Study of Clinical Features of Breakthrough Acinetobacter Bacteremia during Carbapenem Therapy.

Item

http://www.wikidata.org/entity/Q39167693

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Multicenter Study of Clinical ...... mia during Carbapenem Therapy.

@en

Multicenter Study of Clinical ...... mia during Carbapenem Therapy.

@nl

type

Item

label

Multicenter Study of Clinical ...... mia during Carbapenem Therapy.

@en

Multicenter Study of Clinical ...... mia during Carbapenem Therapy.

@nl

prefLabel

Multicenter Study of Clinical ...... mia during Carbapenem Therapy.

@en

Multicenter Study of Clinical ...... mia during Carbapenem Therapy.

@nl

P1476

Multicenter Study of Clinical ...... emia during Carbapenem Therapy

@en

P2093

Chang-Pan Liu

http://www.w3.org/2001/XMLSchema#string

Chung-Ting Chen

http://www.w3.org/2001/XMLSchema#string

Te-Li Chen

http://www.w3.org/2001/XMLSchema#string

Ya-Sung Yang

http://www.w3.org/2001/XMLSchema#string

Yi-Tzu Lee

http://www.w3.org/2001/XMLSchema#string

Yuag-Meng Liu

http://www.w3.org/2001/XMLSchema#string

Yung-Chih Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis

Acinetobacter baumannii: evolution of antimicrobial resistance-treatment options

Species-level identification of isolates of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex by sequence analysis of the 16S-23S rRNA gene spacer region.

Contribution of a plasmid-borne blaOXA-58 gene with its hybrid promoter provided by IS1006 and an ISAba3-like element to beta-lactam resistance in acinetobacter genomic species 13TU.

Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan

Acinetobacter baumannii: emergence of a successful pathogen

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis.

Efficacy of tigecycline for secondary Acinetobacter bacteremia and factors associated with treatment failure.

Pharmacological and patient-specific response determinants in patients with hospital-acquired pneumonia treated with tigecycline

P31

scholarly article

P356

10.1128/AAC.00931-17

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Shu-Chen Kuo

P577

2017-08-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28674056

http://www.w3.org/2001/XMLSchema#string

P921

carbapenem antibiotic

P932

5571354

http://www.w3.org/2001/XMLSchema#string